AZ delivers strong first quarter
The firm said it remains confident in meeting its 2020 expectations
Read More
Tag: first quarter
Generic competition hits AZ’ first-quarter sales
AstraZeneca’s first-quarter performance has taken a hit from generic competition to Crestor, but the firm says the results are no surprise and that it will swing back into the black this year.
Read More
GSK reports Q1 sales decline
GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs.
Read More
Mixed first quarter fortunes for GSK, AZ
UK-based drug giants GlaxoSmithKline and AstraZeneca have reported a mixed bag of results for the first quarter of the year.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
